Clinical Trials Logo

Clinical Trial Summary

Retinitis Pigmentosa is characterized by a progressive disappearance of photoreceptors, responsible for a progressive and severe loss of vision.

People Retinitis Pigmentosa therefore encounter a large number of difficulties in daily life, specifically for:

- Visual research

- Visuo-motor coordination in tasks requiring fine motor control

- Visuo-motor coordination in mobility tasks

This study aims to assess the difficulties in the daily life of subjects with Retinitis Pigmentosa at a very advanced stage unsing, quaify of life questionnaires, simplified locomotion tasks in real situation and a posture task.

They are proposing a new test adapted and carried out in real situations, in binocular and monocular vision, making it possible to finely assess locomotion especially for "very low vision" patients.

This test will also ultimately make it possible to better evaluate the effectivements, that is to say to observe and quantify objectively by a score the performance progression obtained for locomotion tasks related to the visual recovery generated by the treatment.


Clinical Trial Description

This is monocentric study and the total duration of the study is 48 months. The duration of participation for each research subject is 3 months and maximum 4 visits. This is research involving the human type of non-invasive interventional research, with minimal risks and constraints.

This exploratory study will be conducted on a group of patients with Retinitis Pigmentosa at a very advanced stage.

There will be an inclusion visit including a visual assessment and an ophthalmological consultation. Two experimental visits with tests carried out in a real environment including a locomotion and a posture tasks. An end-of-study visit within a maximum of 1 month following the second experimental visit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04419285
Study type Interventional
Source Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Contact Tania TR RILCY
Phone +33140021126
Email trilcy@15-20.fr
Status Recruiting
Phase N/A
Start date March 2, 2020
Completion date June 4, 2024

See also
  Status Clinical Trial Phase
Completed NCT05179460 - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
Recruiting NCT04360291 - Impact of Visual Field Restriction on Visual Exploration
Recruiting NCT05643157 - Cellular Scale Measures of Short-Term Retinal Atrophy Progression
Recruiting NCT03510234 - Self-confidence Study in Patients With Argus II Artificial Retina